|
1
|
Gulewitsch Wl and Amiradžibi S: Ueber das
carnosin, eine neue organische base des Fleischextractes. Berichte
Der Deutschen Chemischen Gesellschaft. 33:1902–1903. 1900.
View Article : Google Scholar
|
|
2
|
Aruoma OI, Laughton MJ and Halliwell B:
Carnosine, homocarnosine and anserine: Could they act as
antioxidants in vivo? Biochem J. 264:863–869. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi SY, Kwon HY, Kwon OB and Kang JH:
Hydrogen peroxide-mediated Cu, Zn-superoxide dismutase
fragmentation: Protection by carnosine, homocarnosine and anserine.
Biochim Biophys Acta. 1472:651–657. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Klebanov GI, Teselkin YuO, Babenkova IV,
Lyubitsky OB, Rebrova OYu, Boldyrev AA and Vladimirov YuA: Effect
of carnosine and its components on free-radical reactions. Membr
Cell Biol. 12:89–99. 1998.PubMed/NCBI
|
|
5
|
Babizhayev MA, Seguin MC, Gueyne J,
Evstigneeva RP, Ageyeva EA and Zheltukhina GA: L-carnosine
(beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act
as natural antioxidants with hydroxyl-radical-scavenging and
lipid-peroxidase activities. Biochem J. 304:509–516. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karton A, O'Reilly RJ, Pattison DI, Davies
MJ and Radom L: Computational design of effective, bioinspired HOCl
antioxidants: The role of intramolecular Cl+ and H+ shifts. J Am
Chem Soc. 134:19240–19245. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chan KM and Decker EA: Endogenous skeletal
muscle antioxidants. Crit Rev Food Sci Nutr. 34:403–426. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kohen R, Yamamoto Y, Cundy KC and Ames BN:
Antioxidant activity of carnosine, homocarnosine, and anserine
present in muscle and brain. Proc Natl Acad Sci USA. 85:pp.
3175–3179. 1988; View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vistoli G, De Maddis D, Cipak A, Zarkovic
N, Carini M and Aldini G: Advanced glycoxidation and lipoxidation
end products (AGEs and ALEs): An overview of their mechanisms of
formation. Free Radic Res. 47 Suppl 1:S3–S27. 2013. View Article : Google Scholar
|
|
10
|
Reddy VP, Garrett MR, Perry G and Smith
MA: Carnosine: A versatile antioxidant and antiglycating agent. Sci
Aging Knowledge Environ. 2005:pe122005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hipkiss AR: Does chronic glycolysis
accelerate aging? could this explain how dietary restriction works?
Ann N Y Acad Sci. 1067:361–368. 2006.PubMed/NCBI
|
|
12
|
Boldyrev AA, Formazyuls VE and Sergienko
VI: Biological significance of histidine-containing dipeptides with
special reference to carnosine: Chemistry, distribution, metabolism
and medical application. Sov Sci Rev D Physicochem Biol. 13:1–60.
1994.
|
|
13
|
Hipkiss AR, Holliday R, McFarland G and
Michaelis J: Carnosine and senescence. Lifespan. 4:1–3. 1993.
|
|
14
|
McFarland GA and Holliday R: Retardation
of the senescence of cultured human fibroblasts by carnosine. Exp
Cell Res. 212:167–175. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harman D: Aging: A Theory Based on Free
Radical and Radiation Chemistry. UCRL Publication no. 3078.
Univesrity of California; Berkrley, CA: 1955
|
|
16
|
Halliwell B and Gutteridge JMC: Free
Radicals in Biology and Medicine. Clarendon Press; Oxford: 1989,
View Article : Google Scholar
|
|
17
|
Schubert D, Behl C, Lesley R, Brack A,
Dargusch R, Sagara Y and Kimua H: Amyloid peptides are toxic via a
common oxidative mechanism. Proc Natl Acad Sci USA. 92:pp.
1989–1993. 1995; View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Libondi T, Ragone R, Vincenli D, Stiuso P,
Auricchio G and Collona G: In vitro cross-linking of calf lens
alpha-crystallin by malondialdehyde. Int J Peptide Protein Res.
44:342–347. 1994. View Article : Google Scholar
|
|
19
|
Hartley A, Stone JM, Heron C, Cooper JM
and Schapira AH: Complex I inhibitors induce dose-dependent
apoptosis in PC12 cells: Relevance to Parkinson's disease. J
Neurochem. 63:1987–1990. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao HM, Hong JS, Zhang W and Liu B:
Distinct role for microglia in rotenone-induced degeneration of
dopaminergic neurons. J Neurosci. 22:782–790. 2002.PubMed/NCBI
|
|
21
|
Freestone PS, Chung KK, Guatteo E, Mercuri
NB, Nicholson LF and Lipski J: Acute action of rotenone on nigral
dopaminergic neurons-involvement of reactive oxygen species and
disruption of Ca2+ homeostasis. Eur J Neurosci. 30:1849–1859. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Caboni P, Sherer TB, Zhang N, Taylor G, Na
HM, Greenamyre JT and Casida JE: Rotenone, deguelin, their
metabolites, and the rat model of Parkinson's disease. Chem Res
Toxicol. 17:1540–1548. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao HM, Hong JS, Zhang W and Liu B:
Synergistic dopaminergic neurotoxicity of the pesticide rotenone
and inflammogen lipopolysaccharide: Relevance to the etiology of
Parkinson's disease. J Neurosci. 23:1228–1236. 2003.PubMed/NCBI
|
|
24
|
Muthuraman P, Kim DH, Muthuviveganandavel
V, Vikramathithan J and Ravikumar S: Differential bio-potential of
ZnS nanoparticles to normal MDCK cells and cervical carcinoma HeLa
cells. J Nanoscience Nanotechnol. 16:8279–8286. 2016. View Article : Google Scholar
|
|
25
|
Muthuraman P, Muthuviveganandavel V and
Kim DH: Cytotoxicity of zinc oxide nanoparticles on antioxidant
enzyme activities and mRNA expression in the cocultured C2C12 and
3T3-L1 cells. Appl Biochem Biotechnol. 175:1270–1280. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Muthuviveganandavel V, Muthuraman P, Muthu
S and Srikumar K: A study of low dose cypermethrin induced
histopathology, lipid peroxidation and marker enzyme changes in
male rats. Pesticide Biochemistry Physiol. 91:12–16. 2008.
View Article : Google Scholar
|
|
27
|
Frankfurt OS and Krishan A:
Apoptosis-based drug screening and detection of selective toxicity
to cancer cells. Anticancer Drugs. 14:555–561. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Markesbery WR: Oxidative stress hypothesis
in Alzheimer's disease. Free Radical Biol Med. 23:134–147. 1997.
View Article : Google Scholar
|
|
29
|
Stadtman ER: Protein oxidation and aging.
Science. 257:1220–1224. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Smith MA, Perry G, Richey PL, Sayre LM,
Anderson VE, Beal MF and Kowall N: Oxidative damage in Alzheimer's.
Nature. 382:120–121. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Smith MA, Rudnicka-Nawrot M, Richey PL,
Praprotnik D, Mulvihill P, Miller CA, Sayre LM and Perry G:
Carbonyl-related post-translational modification of neurofilament
protein in neurofibrillary pathology in Alzheimer's disease. J
Neurochem. 64:2660–2666. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kantha SS, Wada S, Tanaka H, Takeuchi M,
Watabe S and Ochi H: Carnosine sustains the retention of cell
morphology in continuous fibroblast culture subjected to
nutritional insult. Biochem Biophys Res Commun. 223:278–282. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Perry TL, Hansen S, Stedman D and Love D:
Homocarnosine in human cerebrospinal fluid: An age-dependent
phenomenon. J Neurochem. 15:1203–1206. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Das JR and Tizabi Y: Additive protective
effects of donepezil and nicotine against salsolinol-induced
cytotoxicity in SH-SY5Y cells. Neurotox Res. 16:194–204. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Song JX, Shaw PC, Wong NS, Sze CW, Yao XS,
Tang CW, Tong Y and Zhang YB: Chrysotoxine, a novel bibenzyl
compound selectively antagonizes MPP+, but not rotenone,
neurotoxicity in dopaminergic SH-SY5Y cells. Neurosci Lett.
521:76–81. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Storch A, Kaftan A, Burkhardt K and
Schwarz J: 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
(salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells
via impairment of cellular energy metabolism. Brain Res. 855:67–75.
2000. View Article : Google Scholar : PubMed/NCBI
|
